Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Fanconi syndrome associated with SGLT2 inhibitor, canagliflozin. Nephrology (Carlton) 2018 05;23(5):493

Date

04/27/2018

Pubmed ID

29696765

DOI

10.1111/nep.13094

Author List

Esprit DH, Koratala A

Author

Abhilash Koratala MD Assistant Professor in the Medicine department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Acidosis, Renal Tubular
Biomarkers
Blood Glucose
Canagliflozin
Diabetes Mellitus, Type 2
Diabetic Ketoacidosis
Drug Substitution
Fanconi Syndrome
Female
Humans
Insulin
Middle Aged
Treatment Outcome